Martine Zimmermann
Director · LIGAND PHARMACEUTICALS INC
IndividualSelling only
- 2025
- Sep 24, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Martine Zimmermann files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Octavio Espinoza - $13.03M in LGND purchases and sales in the last 12 months
- Andrew Reardon - $10.29M in LGND purchases and sales in the last 12 months
- Jason Haas - $3.74M in LGND purchases and sales in the last 12 months
- Paul Peter Tak - $3.16M in CADL purchases and sales in the last 12 months
- Paul B. Manning - $3.00M in CADL purchases and sales in the last 12 months
- John L. Lamattina - $2.44M in LGND purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Martine Zimmermann?
Martine Zimmermann is a corporate insider, tracked as Director of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Martine Zimmermann submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Martine Zimmermann been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($342K) across all tracked filings.
